Hyperbilirubinemia syndromes (Gilbert-Meulengracht, Crigler-Najjar, Dubin-Johnson, and Rotor syndrome)

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: A multicentre randomised trial

Douillard, J., Cunningham, D., Roth, A., Navarro, M., James, R., Karasek, P., Jandik, P., Iveson, T., Carmichael, J., Alakl, M., et al. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02034-1 · Cited by 3,256 · see citing works

Human UDP-Glucuronosyltransferases: Metabolism, Expression, and Disease

Tukey, R. H., & Strassburg, C. P. (2000) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.40.1.581 · Cited by 1,525 · see citing works

The Genetic Basis of the Reduced Expression of Bilirubin UDP-Glucuronosyltransferase 1 in Gilbert's Syndrome

Bosma, P. J., Chowdhury, J. R., Bakker, C., Gantla, S., Boer, A. M. T., Oostra, B. A., Lindhout, D., Tytgat, G. N. J., Jansen, P. L. M., Elferink, R. P. J. O., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199511023331802 · Cited by 1,439 · see citing works

Genetic Variants in the UDP-glucuronosyltransferase 1A1 Gene Predict the Risk of Severe Neutropenia of Irinotecan

Innocenti, F., Undevia, S. D., Iyer, L., Chen, P. X., Das, S., Kocherginsky, M., Karrison, T. G., Janisch, L. A., Ramı́rez, J., Rudin, C. M., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.07.173 · Cited by 966 · see citing works

Intracellular roles of SN-38, a metabolite of the camptothecin derivative CPT-11, in the antitumor effect of CPT-11.

Kawato, Y., Aonuma, M., Hirota, Y., Kuga, H., & Sato, K. (1991) · PubMed · Cited by 865 · see citing works

Genetic predisposition to the metabolism of irinotecan (CPT-11). Role of uridine diphosphate glucuronosyltransferase isoform 1A1 in the glucuronidation of its active metabolite (SN-38) in human liver microsomes.

Iyer, L., King, C. D., Whitington, P. F., Green, M. D., Roy, S. K., Tephly, T. R., Coffman, B. L., & Ratain, M. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci915 · Cited by 685 · see citing works

Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert's syndrome

Monaghan, G., Ryan, M., Hume, R., et al. (1996) · The Lancet · doi:10.1016/s0140-6736(96)91273-8 · Cited by 590 · see citing works

CHRONIC IDIOPATHIC JAUNDICE WITH UNIDENTIFIED PIGMENT IN LIVER CELLS

Dubin, I. N., & Johnson, F. B. (1954) · Medicine · doi:10.1097/00005792-195409000-00001 · Cited by 454 · see citing works

The apical conjugate efflux pump ABCC2 (MRP2)

Nies, A. T., & KEPPLER, D. O. R. (2006) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-006-0109-y · Cited by 394 · see citing works

Common Human UGT1A Polymorphisms and the Altered Metabolism of Irinotecan Active Metabolite 7-Ethyl-10-hydroxycamptothecin (SN-38)

Gagné, J.-F., Montminy, V., Bélanger, P., Journault, K., Gaucher, G., & Guillemette, C. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.3.608 · Cited by 348 · see citing works

Glucuronidation of Statins in Animals and Humans: A Novel Mechanism of Statin Lactonization

Prueksaritanont, T., Subramanian, R., Fang, X., Ma, B., Qiu, Y., Lin, J. H., Pearson, P. G., & Baillie, T. A. (2002) · Drug Metabolism and Disposition · doi:10.1124/dmd.30.5.505 · Cited by 344 · see citing works

GLUCURONIDATION CONVERTS GEMFIBROZIL TO A POTENT, METABOLISM-DEPENDENT INHIBITOR OF CYP2C8: IMPLICATIONS FOR DRUG-DRUG INTERACTIONS

Ogilvie, B. W., Zhang, D., Li, W., Rodrigues, A. D., Gipson, A. E., Holsapple, J., Toren, P. C., & Parkinson, A. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.007633 · Cited by 331 · see citing works

Association Between the UGT1A1*28 Allele, Bilirubin Levels, and Coronary Heart Disease in the Framingham Heart Study

Lin, J., O’Donnell, C. J., Schwaiger, J. P., et al. (2006) · Circulation · doi:10.1161/circulationaha.106.633206 · Cited by 318 · see citing works

UGT1A1 gene variations and irinotecan treatment in patients with metastatic colorectal cancer

Marcuello, E., Altés, A., Menoyo, A., del Rı́o, E., Gomez-Pardo, M., & Baiget, M. (2004) · British Journal of Cancer · doi:10.1038/sj.bjc.6602042 · Cited by 315 · see citing works

IN VITRO INHIBITION OF UDP GLUCURONOSYLTRANSFERASES BY ATAZANAVIR AND OTHER HIV PROTEASE INHIBITORS AND THE RELATIONSHIP OF THIS PROPERTY TO IN VIVO BILIRUBIN GLUCURONIDATION

Zhang, D., Chando, T. J., Everett, D. W., Patten, C., Dehal, S. S., & Humphreys, W. G. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.105.005447 · Cited by 288 · see citing works

Relevance of Different UGT1A1 Polymorphisms in Irinotecan-Induced Toxicity

Rouits, E., Boisdron‐Celle, M., Dumont, A., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0548 · Cited by 277 · see citing works

Heme oxygenase–carbon monoxide signalling pathway in atherosclerosis: anti-atherogenic actions of bilirubin and carbon monoxide?

Siow, R. C. M. (1999) · Cardiovascular Research · doi:10.1016/s0008-6363(98)00278-8 · Cited by 274 · see citing works

Mechanism of indinavir-induced hyperbilirubinemia

Zucker, S. D., Qin, X., Rouster, S. D., Yu, F., Green, R. M., Keshavan, P., Feinberg, J., & Sherman, K. E. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.231140698 · Cited by 262 · see citing works

UGT1A7 and UGT1A9 Polymorphisms Predict Response and Toxicity in Colorectal Cancer Patients Treated with Capecitabine/Irinotecan

Carlini, L. E., Meropol, N. J., Bever, J. L., Andria, M. L., Hill, T. R., Gold, P. J., Rogatko, A., Wang, H., & Blanchard, R. L. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.1226.11.3 · Cited by 262 · see citing works

Cloning of two human liver bilirubin UDP-glucuronosyltransferase cDNAs with expression in COS-1 cells.

Ritter, J. K., Crawford, J. M., & Owens, I. S. (1991) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35280-8 · Cited by 261 · see citing works

Structure and function of the MRP2 (ABCC2) protein and its role in drug disposition

Jedlitschky, G., Hoffmann, U., & Kroemer, H. K. (2006) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2.3.351 · Cited by 239 · see citing works

Bilirubin: An Endogenous Product of Heme Degradation with Both Cytotoxic and Cytoprotective Properties

Kapitulnik, J. (2004) · Molecular Pharmacology · doi:10.1124/mol.104.002832 · Cited by 239 · see citing works

Genome-wide association meta-analysis for total serum bilirubin levels

Johnson, A. D., Kavousi, M., Smith, A. V., Chen, M., Dehghan, A., Aspelund, T., Lin, J.-P., van Duijn, C. M., Harris, T. B., Cupples, L. A., et al. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp202 · Cited by 234 · see citing works

Gilbert syndrome, UGT1A1*28 allele, and cardiovascular disease risk: Possible protective effects and therapeutic applications of bilirubin

Schwertner, H. A., & Vı́tek, L. (2008) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2008.01.001 · Cited by 224 · see citing works

CHRONIC UNCONJUGATED HYPERBILIRUBINEMIA WITHOUT OVERT SIGNS OF HEMOLYSIS IN ADOLESCENTS AND ADULTS*

Arias, I. M. (1962) · Journal of Clinical Investigation · doi:10.1172/jci104682 · Cited by 220 · see citing works

Predictive Role of the UGT1A1, UGT1A7, and UGT1A9 Genetic Variants and Their Haplotypes on the Outcome of Metastatic Colorectal Cancer Patients Treated With Fluorouracil, Leucovorin, and Irinotecan

Cecchin, E., Innocenti, F., D'Andrea, M. R., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.0314 · Cited by 216 · see citing works

UGT1A1 genotypes and glucuronidation of SN-38, the active metabolite of irinotecan

Ando, Y., Saka, H., Asai, G., et al. (1998) · Annals of Oncology · doi:10.1023/a:1008438109725 · Cited by 207 · see citing works

Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans.

Guillemette, C., Millikan, R. C., Newman, B. M., & Housman, D. E. (2000) · PubMed · Cited by 205 · see citing works

Gilbert Syndrome and the Development of Antiretroviral Therapy–Associated Hyperbilirubinemia

Rotger, M., Taffé, P., Bleiber, G., Günthard, H. F., Furrer, H., Vernazza, P., Drechsler, H., Bernasconi, E., Rickenbach, M., Telenti, A., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/466531 · Cited by 194 · see citing works

GLUCURONIDATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS: IDENTIFYING THE ENZYMES RESPONSIBLE IN HUMAN LIVER MICROSOMES

Kuehl, G. E., Lampe, J. W., Potter, J. D., et al. (2005) · Drug Metabolism and Disposition · doi:10.1124/dmd.104.002527 · Cited by 177 · see citing works

PERSISTENT NONHEMOLYTIC HYPERBILIRUBINEMIA ASSOCIATED WITH LIPOCHROMELIKE PIGMENT IN LIVER CELLS: REPORT OF FOUR CASES

Sprinz, H., & NELSON, R. S. (1954) · Annals of Internal Medicine · doi:10.7326/0003-4819-41-5-952 · Cited by 173 · see citing works

Structural heterogeneity at the UDP-glucuronosyltransferase 1 locus: functional consequences of three novel missense mutations in the human UGT1A7 gene

Guillemette, C., Ritter, J. K., Auyeung, D. J., Kessler, F. K., & Housman, D. E. (2000) · Pharmacogenetics · doi:10.1097/00008571-200010000-00006 · Cited by 169 · see citing works

Hepatobiliary transport

Kullak-Ublick, G. A., Beuers, U. H., & Paumgartner, G. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80411-0 · Cited by 160 · see citing works

Coinheritance of Gilbert Syndrome Increases the Risk for Developing Gallstones in Patients With Hereditary Spherocytosis

del Giudice, E. M., Perrotta, S., Nobili, B., Specchia, C., D’Urzo, G., & Iolascon, A. (1999) · Blood · doi:10.1182/blood.v94.7.2259.419k42_2259_2262 · Cited by 159 · see citing works

The Glucuronidation of Exogenous and Endogenous Compounds by Stably Expressed Rat and Human UDP-Glucuronosyltransferase 1.1

King, C. D., Green, M. D., Rios, G. R., et al. (1996) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.1996.0320 · Cited by 159 · see citing works

Haplotype structure of the UDP-glucuronosyltransferase 1A1 promoter in different ethnic groups.

Innocenti, F., Grimsley, C., Das, S., et al. (2002) · Pharmacogenetics · doi:10.1097/00008571-200212000-00006 · Cited by 156 · see citing works

Identification of a genetic alteration in the code for bilirubin UDP-glucuronosyltransferase in the UGT1 gene complex of a Crigler-Najjar type I patient.

Ritter, J. K., Yeatman, M. T., Ferreira, P., et al. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115829 · Cited by 149 · see citing works

Inhibition of human organic anion transporting polypeptide OATP 1B1 as a mechanism of drug-induced hyperbilirubinemia

Campbell, S. D., de Morais, S. M., & Xu, J. J. (2004) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2004.08.008 · Cited by 147 · see citing works

IDENTIFICATION OF HUMAN UDP-GLUCURONOSYLTRANSFERASE ENZYME(S) RESPONSIBLE FOR THE GLUCURONIDATION OF EZETIMIBE (ZETIA)

Ghosal, A., Hapangama, N., Yuan, Y., Achanfuo-Yeboah, J., Iannucci, R., Chowdhury, S. K., Alton, K. B., Patrick, J. E., & Zbáida, S. (2004) · Drug Metabolism and Disposition · doi:10.1124/dmd.32.3.314 · Cited by 143 · see citing works

Glucuronidation of 7-Ethyl-10-hydroxycamptothecin (SN-38) by the Human UDP-Glucuronosyltransferases Encoded at the UGT1 Locus

Ciotti, M., Basu, N. K., Brangi, M., & Owens, I. S. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.0453 · Cited by 141 · see citing works

Gilbert's disease and atazanavir: From phenotype to UDP-glucuronosyltransferase haplotype

Lankisch, T. O., Moebius, U., Wehmeier, M., et al. (2006) · Hepatology · doi:10.1002/hep.21361 · Cited by 138 · see citing works

Polymorphisms of the human UDP-glucuronosyltransferase (UGT) 1A7 gene in colorectal cancer

Strassburg, C. P. (2002) · Gut · doi:10.1136/gut.50.6.851 · Cited by 136 · see citing works

Interaction between Oxidative Stress Sensor Nrf2 and Xenobiotic-activated Aryl Hydrocarbon Receptor in the Regulation of the Human Phase II Detoxifying UDP-glucuronosyltransferase 1A10

Kalthoff, S., Ehmer, U., Freiberg, N., Manns, M. P., & Strassburg, C. P. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.075770 · Cited by 129 · see citing works

Coffee Induces Expression of Glucuronosyltransferases by the Aryl Hydrocarbon Receptor and Nrf2 in Liver and Stomach

Kalthoff, S., Ehmer, U., Freiberg, N., Manns, M. P., & Strassburg, C. P. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.06.048 · Cited by 124 · see citing works

A common Dubin-Johnson syndrome mutation impairs protein maturation and transport activity of MRP2 (ABCC2)

Keitel, V., Nies, A. T., Brom, M., Hummel-Eisenbeiss, J., Spring, H., & KEPPLER, D. O. R. (2003) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00362.2002 · Cited by 122 · see citing works

Human bilirubin UDP-glucuronosyltransferase catalyzes the glucuronidation of ethinylestradiol.

Ebner, T., Remmel, R. P., & Burchell, B. (1993) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13456-1 · Cited by 121 · see citing works

Pharmacogenomics of Human UDP-Glucuronosyltransferases and Irinotecan Toxicity

Tukey, R. H., Strassburg, C. P., & Mackenzie, P. I. (2002) · Molecular Pharmacology · doi:10.1124/mol.62.3.446 · Cited by 120 · see citing works

The role of phospholipids in bile formation: what can we learn from animals and human disease?

Elferink, R. O., Marleen, D. V., Charles, F., et al. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80431-6 · Cited by 115 · see citing works

A mutation in bilirubin uridine 5′-diphosphate-glucuronosyltransferase isoform 1 causing Crigler-Najjar syndrome type II

Bosma, P. J., Goldhoorn, B. G., Elferink, R. P. J. O., et al. (1993) · Gastroenterology · doi:10.1016/0016-5085(93)90029-c · Cited by 101 · see citing works

Abnormal Hepatic Transport of Indocyanine Green in Gilbert's Syndrome

Martin, J. F., Vierling, J. M., Wolkoff, A. W., et al. (1976) · Gastroenterology · doi:10.1016/s0016-5085(76)80151-5 · Cited by 99 · see citing works

Characterization of benzo(a)pyrene-trans-7,8-dihydrodiol glucuronidation by human tissue microsomes and overexpressed UDP-glucuronosyltransferase enzymes.

Fang, J., Beland, F. A., Doerge, D. R., et al. (2002) · PubMed · Cited by 98 · see citing works

UGT1A1*6 polymorphism is most predictive of severe neutropenia induced by irinotecan in Japanese cancer patients

Onoue, M., Terada, T., Kobayashi, M., et al. (2009) · International Journal of Clinical Oncology · doi:10.1007/s10147-008-0821-z · Cited by 97 · see citing works

Glucuronidation of Catechol Estrogens by Expressed Human UDP-Glucuronosyltransferases (UGTs) 1A1, 1A3, and 2B7,

Cheng, Z. (1998) · Toxicological Sciences · doi:10.1006/toxs.1998.2494 · Cited by 97 · see citing works

Association of genetic polymorphisms in UGT1A1 with breast cancer and plasma hormone levels.

Guillemette, C., Vivo, I. D., Hankinson, S. E., Haiman, C. A., Spiegelman, D. L., Housman, D. E., & Hunter, D. J. (2001) · PubMed · Cited by 94 · see citing works

Defective Bromosulfophthalein Clearance in Patients with Constitutional Hepatic Dysfunction (Gilbert's Syndrome)

Berk, P. D., Blaschke, T. F., & Waggoner, J. G. (1972) · Gastroenterology · doi:10.1016/s0016-5085(19)33296-2 · Cited by 94 · see citing works

UGT1A1 variation and gallstone formation in sickle cell disease

Haverfield, E. V., McKenzie, C. A., Forrester, T., et al. (2004) · Blood · doi:10.1182/blood-2004-02-0521 · Cited by 93 · see citing works

Gilbert's Syndrome and Irinotecan Toxicity: Combination with UDP-Glucuronosyltransferase 1A7 Variants Increases Risk

Lankisch, T. O., Schulz, C. U., Zwingers, T., Erichsen, T. J., Manns, M. P., Heinemann, V., & Strassburg, C. P. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2517 · Cited by 93 · see citing works

UGT1A1Promoter Genotype Correlates With SN-38 Pharmacokinetics, but Not Severe Toxicity in Patients Receiving Low-Dose Irinotecan

Stewart, C. F., Panetta, J. C., O'Shaughnessy, M. A., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.2301 · Cited by 92 · see citing works

The Functional UGT1A1 Promoter Polymorphism Decreases Endometrial Cancer Risk

Duguay, Y., McGrath, M., Lépine, J., Gagné, J.-F., Hankinson, S. E., Colditz, G. A., Hunter, D. J., Plante, M., Têtu, B., Bélanger, A., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3295 · Cited by 89 · see citing works

Disruption of the Ugt1 Locus in Mice Resembles Human Crigler-Najjar Type I Disease

Nguyen, N. T., Bonzo, J. A., Chen, S., et al. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m709244200 · Cited by 88 · see citing works

UDP-glucuronosyltransferase and sulfotransferase polymorphisms, sex hormone concentrations, and tumor receptor status in breast cancer patients

Sparks, R., Ulrich, C. M., Bigler, J., et al. (2004) · Breast Cancer Research · doi:10.1186/bcr818 · Cited by 85 · see citing works

The linear effects of α‐thalassaemia, the UGT1A1 and HMOX1 polymorphisms on cholelithiasis in sickle cell disease

Vasavda, N., Menzel, S., Kondaveeti, S., Maytham, E. G., Awogbade, M., Bannister, S., Cunningham, J., Eichholz, A., Daniel, Y., Okpala, I. E., et al. (2007) · British Journal of Haematology · doi:10.1111/j.1365-2141.2007.06643.x · Cited by 83 · see citing works

Identification and Characterization of a Functional TATA Box Polymorphism of the UDP Glucuronosyltransferase 1A7 Gene

Lankisch, T. O., Vogel, A., Eilermann, S., Fiebeler, A., Krone, B., Barut, A., Manns, M. P., & Strassburg, C. P. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.007146 · Cited by 78 · see citing works

Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 (UGT1A1) and risk of breast cancer

Adegoke, O. J., Shu, X. O., Gao, Y., et al. (2004) · Breast Cancer Research and Treatment · doi:10.1023/b:brea.0000025419.26423.b8 · Cited by 76 · see citing works

Bilirubin and the risk of common non-hepatic diseases

Rigato, I., Ostrow, J. D., & Tiribelli, C. (2005) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2005.04.008 · Cited by 71 · see citing works

A phenylalanine codon deletion at the UGT1 gene complex locus of a Crigler-Najjar type I patient generates a pH-sensitive bilirubin UDP-glucuronosyltransferase.

Ritter, J. K., Yeatman, M. T., Kaiser, C. A., et al. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)49501-x · Cited by 68 · see citing works

Coinheritance of Gilbert syndrome–associated UGT1A1 mutation increases gallstone risk in cystic fibrosis†

Wasmuth, H. E., Keppeler, H., Herrmann, U., et al. (2006) · Hepatology · doi:10.1002/hep.21105 · Cited by 66 · see citing works

Comparison of stably expressed rat UGT1.1 and UGT2B1 in the glucuronidation of opioid compounds.

King, C. D., Rios, G. R., Green, M. D., et al. (1997) · PubMed · Cited by 63 · see citing works

Variability and Function of Family 1 Uridine-5′-Diphosphate Glucuronosyltransferases (UGT1A)

Strassburg, C. P., Kalthoff, S., & Ehmer, U. (2008) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408360802374624 · Cited by 63 · see citing works

Inhibition of bilirubin metabolism induces moderate hyperbilirubinemia and attenuates ANG II-dependent hypertension in mice

Vera, T., Granger, J. P., & Stec, D. E. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.90889.2008 · Cited by 61 · see citing works

Link between colorectal cancer and polymorphisms in the uridine-diphosphoglucuronosyltransferase1A7and1A1genes

Tang, K.-S. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i21.3250 · Cited by 61 · see citing works

Gilbert-Meulengracht’s syndrome and pharmacogenetics: is jaundice just the tip of the iceberg?

Strassburg, C. P. (2009) · Drug Metabolism Reviews · doi:10.3109/03602530903209429 · Cited by 59 · see citing works

Irinogenetics: What Is the Right Star?

Innocenti, F., Vokes, E. E., & Ratain, M. J. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.05.2464 · Cited by 58 · see citing works

Association between the UGT1A1 TA-Repeat Polymorphism and Bilirubin Concentration in Patients with Intermittent Claudication: Results from the CAVASIC Study

Rantner, B., Kollerits, B., Anderwald-Stadler, M., et al. (2008) · Clinical Chemistry · doi:10.1373/clinchem.2007.102046 · Cited by 56 · see citing works

Correlation between the UDP-Glucuronosyltransferase (UGT1A1) TATAA Box Polymorphism and Carcinogen Detoxification Phenotype

Fang, J., & Lazarus, P. J. (2004) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-03-0070 · Cited by 56 · see citing works

Inactivation of the Pure Antiestrogen Fulvestrant and Other Synthetic Estrogen Molecules by UDP-Glucuronosyltransferase 1A Enzymes Expressed in Breast Tissue

Chouinard, S., Tessier, M., Vernouillet, G., Gauthier, S., Labrie, F., Barbier, O., & Bélanger, A. (2005) · Molecular Pharmacology · doi:10.1124/mol.105.015891 · Cited by 54 · see citing works

Gilbert’s syndrome and hyperbilirubinemia in protease inhibitor therapy – An extended haplotype of genetic variants increases risk in indinavir treatment

Lankisch, T. O., Behrens, G. M. N., Ehmer, U., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.030 · Cited by 53 · see citing works

Alteration of drug metabolism in Gilbert's syndrome.

Carulli, N., de Leòn, M. P., Mauro, E., et al. (1976) · Gut · doi:10.1136/gut.17.8.581 · Cited by 51 · see citing works

Jaundice, genes and promoters

Strassburg, C. P., & Manns, M. P. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80285-8 · Cited by 46 · see citing works

Irinotecan treatment in cancer patients with UGT1A1 polymorphisms.

Innocenti, F., & Ratain, M. J. (2003) · PubMed · Cited by 44 · see citing works

Conditional linkage and genome-wide association studies identify UGT1A1 as a major gene for anti-atherogenic serum bilirubin levels—The Framingham Heart Study

Lin, J. P., Schwaiger, J. P., Cupples, L. A., O’Donnell, C. J., Zheng, G., Schoenborn, V., Hunt, S. C., Joo, J., & Kronenberg, F. (2009) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2009.02.039 · Cited by 42 · see citing works

Gilbert??s Syndrome and Drug Metabolism

MacKlon, A. F., Savage, R. L., & Rawlins, M. D. (1979) · Clinical Pharmacokinetics · doi:10.2165/00003088-197904030-00004 · Cited by 41 · see citing works

Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis

Ribrag, V., Koscielny, S., Casasnovas, O., et al. (2008) · Blood · doi:10.1182/blood-2008-03-148874 · Cited by 39 · see citing works

Further Evidence That the UGT1A1*28 Allele Is Not Associated with Coronary Heart Disease: The ECTIM Study

Gajdos, V., Petit, F. M., Perret, C., et al. (2006) · Clinical Chemistry · doi:10.1373/clinchem.2006.078667 · Cited by 37 · see citing works

New insights into the classification and mechanisms of hereditary, chronic, non-haemolytic hyperbilirubinaemias

Berthelot, P., & Dhumeaux, D. (1978) · Gut · doi:10.1136/gut.19.6.474 · Cited by 36 · see citing works

Citrus Fruit Intake Is Associated with Lower Serum Bilirubin Concentration among Women with the UGT1A1*28 Polymorphism

Saracino, M. R., Bigler, J., Schwarz, Y., Chang, J.-L., Li, S., Li, L., White, E., Potter, J. D., & Lampe, J. W. (2009) · Journal of Nutrition · doi:10.3945/jn.108.097279 · Cited by 34 · see citing works

Rapid Allelic Discrimination by TaqMan PCR for the Detection of the Gilbert's Syndrome Marker UGT1A1*28

Ehmer, U., Lankisch, T. O., Erichsen, T. J., et al. (2008) · Journal of Molecular Diagnostics · doi:10.2353/jmoldx.2008.080036 · Cited by 32 · see citing works

Downregulation of the hepatocellular organic anion transporters OATP-C and MRP2 in patients with primary sclerosing cholangitis

Oswald, M., Kullak-Ublick, G. A., Paumgartner, G., et al. (2000) · Journal of Hepatology · doi:10.1016/s0168-8278(00)80787-4 · Cited by 32 · see citing works

Genetic variations in UGT1A1 and UGT2B7 and endometrial cancer risk

McGrath, M., Lépine, J., Lee, I., et al. (2009) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e328323f66c · Cited by 27 · see citing works

The Contribution of Intestinal UDP-Glucuronosyltransferases in Modulating 7-Ethyl-10-hydroxy-camptothecin (SN-38)-Induced Gastrointestinal Toxicity in Rats

Tallman, M. N., Miles, K. K., Kessler, F. K., et al. (2006) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.106.110924 · Cited by 27 · see citing works

Effects of Japanese Herbal Medicine, Kampo, on Human UGT1A1 Activity

Katoh, M., Yoshioka, Y., Nakagawa, N., et al. (2009) · Drug Metabolism and Pharmacokinetics · doi:10.2133/dmpk.24.226 · Cited by 27 · see citing works

Rotor‐type hyperbilirubinaemia has no defect in the canalicular bilirubin export pump

Hřebı́ček, M., Jirásek, T., Hartmannová, H., et al. (2007) · Liver International · doi:10.1111/j.1478-3231.2007.01446.x · Cited by 26 · see citing works

A new diagnostic approach to the Dubin-Johnson syndrome.

Pinós, T., Jm, C., Palacı́n, A., et al. (1990) · PubMed · Cited by 25 · see citing works

Biliary Excretion of Conjugated Sulfobromophthalein (BSP) in Constitutional Conjugated Hyperbilirubinemias

Abe, H., & Okuda, K. (2009) · Digestion · doi:10.1159/000197719 · Cited by 23 · see citing works

Hepatic transport of serum bilirubin, bromsulfophthalein, and indocyanine green in patients with congenital non-hemolytic hyperbilirubinemia and patients with constitutional indocyanine green excretory defect

Nambu, M., & Namihisa, T. (1996) · Journal of Gastroenterology · doi:10.1007/bf02389522 · Cited by 18 · see citing works

Gilbert’s syndrome and antiviral therapy of hepatitis C

Deterding, K., Grüngreiff, K., Lankisch, T. O., et al. (2009) · Annals of Hepatology · doi:10.1016/s1665-2681(19)31774-0 · Cited by 16 · see citing works

Chronic idiopathic jaundice with unidentified pigment in the liver cells : a new clinico-pathological entity with report of twelve cases

Dubin, I. N. (1954) · Medical Entomology and Zoology · Cited by 14 · see citing works

Caffeine clearance in subjects with constitutional unconjugated hyperbilirubinemia.

Testa, R., Bardellini, E., Borzone, S., et al. (1995) · PubMed · Cited by 4 · see citing works

Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial

Aldrich, C., Leroux–Roels, I., Huang, K. B., Bica, M. A., Loeliger, E., Schoenborn-Kellenberger, O., Walz, L., Leroux-Roels, G., von Sonnenburg, F., & Oostvogels, L. (2021) · Vaccine · doi:10.1016/j.vaccine.2020.12.070 · Cited by 204 · see citing works

Diagnostic criteria and contributors to Gilbert’s syndrome

Wagner, K.-H., Shiels, R. G., Lang, C. A., Seyed Khoei, N., & Bulmer, A. C. (2018) · Critical Reviews in Clinical Laboratory Sciences · doi:10.1080/10408363.2018.1428526 · Cited by 138 · see citing works

Radiographic Pathognomonic Findings of Leprosy: A Report of Two Cases

Zizmor, J., & Lesnik, T. H. (1972) · Archives of Otolaryngology - Head and Neck Surgery · doi:10.1001/archotol.1972.00770090854016 · Cited by 1 · see citing works

The Interpretive Significance of Pathognomonic Signs

Koziol, L. F., Beljan, P., Bree, K., Mather, J., & Barker, L. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-28222-0_5

Imaging of Pathognomonic Findings of Benign Breast Lesions

Youk, J. H., & Ojeda‐Fournier, H. (2017) · Contemporary Diagnostic Radiology · doi:10.1097/01.cdr.0000520673.18804.65 · Cited by 1 · see citing works

Experimental infection of Atlantic salmon, Salmo salar L., with infectious salmon anaemia virus: a histopathological study

Simko, E., Brown, L. L., MacKinnon, A., et al. (2000) · Journal of Fish Diseases · doi:10.1046/j.1365-2761.2000.00203.x · Cited by 22 · see citing works

Fibrolipomatous hamartoma of the median nerve on CT

Maldjian, C. (2013) · Radiology Case Reports · doi:10.2484/rcr.v8i4.895 · Cited by 2 · see citing works